Gabriel Brooks
Chief Medical Officer · 4 filings · Latest: Feb 13, 2026
Solid Biosciences Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SLDB | Brooks Gabriel | — | Feb 18, 2026 | Proposed Sale | $5.82 | 5,563 | $32.4K | — | |
SLDB | Gabriel Brooks | Chief Medical Officer | Feb 18, 2026 | Sale | $5.82 | 0 | — | 89,466 | |
SLDB | Gabriel Brooks | Chief Medical Officer | Feb 13, 2026 | Option Exercise | — | 10,937 | — | 95,029 | |
SLDB | Gabriel Brooks | Chief Medical Officer | Feb 4, 2026 | Sale | $6.44 | 12,616 | $81.3K | 84,092 | |
SLDB | Brooks Gabriel | — | Feb 4, 2026 | Proposed Sale | $6.44 | 12,616 | $81.3K | — | |
SLDB | Gabriel Brooks | Chief Medical Officer | Feb 2, 2026 | Sale | $6.44 | 28,335 | $182.4K | 96,708 | |
SLDB | Gabriel Brooks | Chief Medical Officer | Jan 31, 2026 | Option Exercise | — | 28,225 | — | 125,043 | |
SLDB | Gabriel Brooks | Chief Medical Officer | Jan 29, 2026 | Option Exercise | — | 58,847 | — | 96,818 | |
SLDB | Brooks Gabriel | — | Feb 2, 2026 | Proposed Sale | $6.44 | 28,335 | $182.4K | — |